Trace Amine-associated Receptor (TAAR)

微量胺相关受体 (TAAR) 是一类 G 蛋白偶联受体,于 2001 年被发现。人类拥有六种功能同工型 (TAAR1、TAAR2、TAAR5、TAAR6、TAAR8 和 TAAR9),而一些鱼类物种表达超过 100 种。它充当微量胺的内源性受体。微量胺是内源性化合物,传统上被认为包含 β-苯乙胺、对酪胺、色胺、对章胺及其一些代谢物。

尽管所有其他 TAAR 主要或专门用作主要嗅觉系统中的化学感应受体,但已证明 TAAR 1 是大脑中多巴胺、血清素和谷氨酸活性的新型调节剂。TAAR 1 已被确定为精神分裂症、抑郁症和成瘾症的新治疗靶点。在外周,TAAR1 调节营养诱导的激素分泌,表明其有可能成为糖尿病和肥胖症的新治疗靶点。TAAR1 还可以通过调节白细胞分化和活化来调节免疫反应。

Trace amine associated-receptors (TAARs) are a class of G protein-coupled receptors that were discovered in 2001. Humans possess six functional isoforms (TAAR1, TAAR2, TAAR5, TAAR6, TAAR8, and TAAR9), whereas some fish species express over 100. It acts as an endogenous receptor for the trace amines. Trace amines are endogenous compounds classically regarded as comprising β-phenylethyalmine, p-tyramine, tryptamine, p-octopamine, and some of their metabolites.

Although all other TAARs serve predominantly or exclusively as chemosensory receptors in the main olfactory system, TAAR 1 has been demonstrated to be a novel modulator of dopaminergic, serotonergic and glutamatergic activity in the brain. And TAAR 1 has been identified as a novel therapeutic target for schizophrenia, depression, and addiction. In the periphery, TAAR1 regulates nutrient-induced hormone secretion, suggesting its potential as a novel therapeutic target for diabetes and obesity. TAAR1 may also regulate immune responses by regulating leukocyte differentiation and activation.

共 1种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
RTI-7470-44

RTI-7470-44 是一种口服有效且可透过血脑屏障的微量胺相关受体 1 (hTAAR1) 拮抗剂(Ki = 0.3 nM),可抑制 hTAAR1 介导的 cAMP 生成与信号传导(IC50 = 8.4 nM)并阻断 hTAAR1 介导的 GIRK 电流反应,同时能提高多巴胺能神经元的自发放电频率、降低胶原诱导的血小板聚集,可用于帕金森病和胃排空的相关研究。

825658-63-7
Antagonist
99.85%
RTI-7470-44

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础